CM Life Sciences, Inc. Uncategorized Contracts & Agreements
28 Contracts & Agreements
- Description of Securities (Filed With SEC on February 23, 2024)
- Form of Option Award Agreement under the 2023 Equity Inducement Plan (Filed With SEC on July 24, 2023)
- GeneDx Holdings Corp. 2023 Equity Inducement Plan (Filed With SEC on July 24, 2023)
- Letter Agreement, Amendment No. 2 to Sub-Sublease, dated as of March 20, 2023, by and between Icahn School of Medicine at Mount Sinai and the Company (Filed With SEC on May 9, 2023)
- Amendment No. 1 to (Filed With SEC on April 14, 2023)
- Amendment No. 1 to BioMe Biospecimen and Data Access Agreement, dated as of January 19, 2023, by and between Icahn School of Medicine at Mount Sinai and Sema4 OpCo, Inc (Filed With SEC on March 16, 2023)
- Description of Securities (Filed With SEC on March 16, 2023)
- Amendment No.1 to the (Filed With SEC on June 14, 2022)
- Executive Chairman Agreement, date (Filed With SEC on March 14, 2022)
- Description of Securities (Filed With SEC on March 14, 2022)
- Sub-Sublease, dated as of June 6, 2017, by and between Icahn School of Medicine at Mount Sinai and the Company, as amended July 31, 2019 (Filed With SEC on July 28, 2021)
- Form of Earn-Out RSU Agreement (Filed With SEC on July 28, 2021)
- Amended and Restated (Filed With SEC on July 28, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Nat Turner (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Emily Leproust (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Munib Islam (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Sean George (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Shaun Rodriguez (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Brian Emes (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Keith Meister (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Eli Casdin (Filed With SEC on March 30, 2021)
- Description of the Companys securities (Filed With SEC on March 30, 2021)
- Forfeiture Agreement, dated as of February 9, 2021, by and between CMLS Holdings LLC and Mount Sinai Genomics, Inc. d/b/a Sema4 (Filed With SEC on February 11, 2021)
- Sponsor Support Agreement, dated as of February 9, 2021, by and among CMLS Holdings LLC, CM Life Sciences, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4 (Filed With SEC on February 11, 2021)
- Letter Agreement, dated September 1, 2020, by and among the Company, its officers, its directors and CMLS Holdings LLC (Filed With SEC on September 4, 2020)
- Form of Indemnity Agreement (Filed With SEC on August 24, 2020)
- Form of Letter Agreement among the Registrant, CMLS Holdings LLC and each of the executive officers and directors of the Registrant (Filed With SEC on August 24, 2020)
- Specimen Unit Certificate (Filed With SEC on August 24, 2020)
